DK0544210T3 - Fremgangsmåde til fremstilling af i 5-stillingen substituerede cytosiner og andre 4,5-disubstituerede pyrimidin-2 (1H) -one - Google Patents

Fremgangsmåde til fremstilling af i 5-stillingen substituerede cytosiner og andre 4,5-disubstituerede pyrimidin-2 (1H) -one

Info

Publication number
DK0544210T3
DK0544210T3 DK92119912T DK92119912T DK0544210T3 DK 0544210 T3 DK0544210 T3 DK 0544210T3 DK 92119912 T DK92119912 T DK 92119912T DK 92119912 T DK92119912 T DK 92119912T DK 0544210 T3 DK0544210 T3 DK 0544210T3
Authority
DK
Denmark
Prior art keywords
preparation
position substituted
substituted cytosines
formula
disubstituted pyrimidin
Prior art date
Application number
DK92119912T
Other languages
Danish (da)
English (en)
Inventor
Gerhard Dr Johne
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0544210T3 publication Critical patent/DK0544210T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK92119912T 1991-11-23 1992-11-23 Fremgangsmåde til fremstilling af i 5-stillingen substituerede cytosiner og andre 4,5-disubstituerede pyrimidin-2 (1H) -one DK0544210T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4138585 1991-11-23

Publications (1)

Publication Number Publication Date
DK0544210T3 true DK0544210T3 (da) 2000-04-25

Family

ID=6445453

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92119912T DK0544210T3 (da) 1991-11-23 1992-11-23 Fremgangsmåde til fremstilling af i 5-stillingen substituerede cytosiner og andre 4,5-disubstituerede pyrimidin-2 (1H) -one

Country Status (9)

Country Link
US (1) US5359067A (ko)
EP (1) EP0544210B1 (ko)
JP (1) JP3261181B2 (ko)
KR (1) KR100273823B1 (ko)
AT (1) ATE186300T1 (ko)
CA (1) CA2083436C (ko)
DE (1) DE59209762D1 (ko)
DK (1) DK0544210T3 (ko)
TW (1) TW225525B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6792700A (en) * 1999-08-20 2001-03-19 Research Foundation Of The State University Of New York, The 5-propynylpyrimidine derivatives as cytotoxic enzyme inhibitors
CN1302004C (zh) * 2003-08-22 2007-02-28 浙江海正药业股份有限公司 一种阿糖胞苷的制备方法
JP7413362B2 (ja) 2019-03-29 2024-01-15 シスメックス株式会社 新規人工核酸、その製造方法及び用途
WO2020226889A1 (en) * 2019-05-07 2020-11-12 Wellstat Therapeutics Corporation Formulations of uridine triacetate in triacetin
EP4219517A1 (en) 2020-09-25 2023-08-02 Riken Genesis Co., Ltd. Novel artificial nucleic acid, method for producing same, and use thereof

Also Published As

Publication number Publication date
CA2083436C (en) 2004-05-11
JPH05222034A (ja) 1993-08-31
ATE186300T1 (de) 1999-11-15
TW225525B (ko) 1994-06-21
JP3261181B2 (ja) 2002-02-25
CA2083436A1 (en) 1993-05-24
EP0544210A1 (de) 1993-06-02
KR930010007A (ko) 1993-06-21
EP0544210B1 (de) 1999-11-03
DE59209762D1 (de) 1999-12-09
US5359067A (en) 1994-10-25
KR100273823B1 (ko) 2000-12-15

Similar Documents

Publication Publication Date Title
TW274550B (ko)
LU90284I2 (fr) Montelukast ou un sel pharmaceutiquement acceptable de montelukast en particulier le sel de sodium de montelukast
ES2072276T5 (es) Alfa-arilacrilatos substituidos con heterociclos y fungicidas que contienen estos compuestos.
SE8105240L (sv) Teofyllin- och teobrominderivat
ES8504741A1 (es) Procedimiento para la preparacion de nuevos derivados de pirimidina o s-triacina.
DK0544210T3 (da) Fremgangsmåde til fremstilling af i 5-stillingen substituerede cytosiner og andre 4,5-disubstituerede pyrimidin-2 (1H) -one
ES2078876A1 (es) Una composicion herbicida a base de fenilpirazol 3-sustituidos.
NZ195450A (en) Regulating plant growth with 1-phenoxy-3 3-dimethyl-2-(pyrimidin-5-yl) butan-2-ols
PL238801A2 (en) Fungicide
DK0526588T3 (da) Heterocykliske forbindelser, deres fremstilling og anvendelse
MC1919A1 (fr) Derives de l'imidazole
AU639612B2 (en) Hydroxyalkylquinoline ether acids as leukotriene antagonists
FI925258A (fi) Foerfarande foer framstaellning av 2-substituerade 4,6-dialkoxipyrimidiner
FI913722A (fi) Foerfarande foer framstaellning av deoxinukleosider.
ES2089971B1 (es) Procedimiento de preparacion de 2-(4-(4-(4 cloro-1-pirazolil)-piperacinil)pirimidina (lesopitron).
DE3271755D1 (en) 5-aminomethyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives